Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer

SIMPLE SUMMARY: The heterogeneity of complicated diseases like cancer negatively affects patients’ responses to treatment. Finding homogeneous subgroups of patients within the cancer population and finding the appropriate treatment for each subgroup will improve patients’ survival. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Taie, Zainab, Hannink, Mark, Mitchem, Jonathan, Papageorgiou, Christos, Shyu, Chi-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699385/
https://www.ncbi.nlm.nih.gov/pubmed/34944904
http://dx.doi.org/10.3390/cancers13246278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699385/
https://www.ncbi.nlm.nih.gov/pubmed/34944904
http://dx.doi.org/10.3390/cancers13246278

Ejemplares similares